Clock.bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5.3M
- Investors
-
6
Clock.bio General Information
Description
Operator of a stem cell research firm intended to extend and improve quality of life by reversing the harmful effects of time in cells. The company specializes in developing novel treatments that can prevent and treat age-related diseases and decode the rejuvenation programs present in human cells to increase human healthspan, enabling humans to utilize regenerative capabilities.
Contact Information
Website
www.clock.bioCorporate Office
- Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre
- University of Cambridge, Puddicombe Way
- Cambridge CB2 0AW
- England, United Kingdom
Corporate Office
- Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre
- University of Cambridge, Puddicombe Way
- Cambridge CB2 0AW
- England, United Kingdom
Clock.bio Timeline
Clock.bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 30-Jun-2024 | $5.3M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 01-Sep-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jan-2023 | $478K | $681K | Completed | Generating Revenue | |
| 1. Early Stage VC | 30-Dec-2021 | $203K | $203K | Completed | Startup |
Clock.bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed -2 Preferred | ||||||||
| Seed -1 Preferred | ||||||||
| Ordinary | 166,412 | $0.000010 | $2.36 | $2.36 | $2.36 | 8.01% | ||
| A Ordinary | 163,317 | $0.000010 | $0.93 | $0.93 | $0.93 | 7.86% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Clock.bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Clock.bio Patents
Clock.bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202415992-D0 | Novel targets for the modulation of ageing | Pending | 30-Oct-2024 | ||
| GB-202414318-D0 | Novel targets for the modulation of ageing | Inactive | 30-Sep-2024 | ||
| GB-202409874-D0 | Novel cells and methods | Pending | 08-Jul-2024 | ||
| GB-202402045-D0 | Novel targets for the modulation of ageing | Inactive | 14-Feb-2024 | ||
| GB-202316499-D0 | Novel targets for the modulation of ageing | Inactive | 27-Oct-2023 |
Clock.bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Clock.bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Meltwind Advisory | Venture Capital | Minority | ||
| Onsight Ventures | Venture Capital | Minority | ||
| Phoenix Court | Venture Capital | Minority | ||
| Firstminute Capital | Venture Capital | Minority |
Clock.bio FAQs
-
When was Clock.bio founded?
Clock.bio was founded in 2020.
-
Where is Clock.bio headquartered?
Clock.bio is headquartered in Cambridge, United Kingdom.
-
What is the size of Clock.bio?
Clock.bio has 9 total employees.
-
What industry is Clock.bio in?
Clock.bio’s primary industry is Biotechnology.
-
Is Clock.bio a private or public company?
Clock.bio is a Private company.
-
What is the current valuation of Clock.bio?
The current valuation of Clock.bio is .
-
What is Clock.bio’s current revenue?
The current revenue for Clock.bio is .
-
How much funding has Clock.bio raised over time?
Clock.bio has raised $10M.
-
Who are Clock.bio’s investors?
, Meltwind Advisory, Onsight Ventures, Phoenix Court, and Firstminute Capital are 5 of 6 investors who have invested in Clock.bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
